About Antares Medicines For Partners For Investors For PatientsCareers Contact Us Recent News Information contained in these press releases should be considered accurate only as of the date it was prepared. Information may change over time. Do not assume that the information remains accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website. 22 November 2021 Antares Pharma to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference 10 November 2021 Antares Pharma to Present at the Jefferies London Healthcare Conference 04 November 2021 Antares Pharma Reports Third Quarter 2021 Financial and Operating Results 28 October 2021 Antares Pharma Announces Appointment of Carmen Volkart to its Board of Directors 25 October 2021 Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of SMSNA 21 October 2021 Antares Pharma to Report Third Quarter 2021 Financial and Operating Results 18 October 2021 Antares Pharma Enters Into Exclusive License Agreement with Lipocine for TLANDO® in U.S. 30 September 2021 Antares Pharma Initiates Phase I Study for ATRS-1902 for Adrenal Crisis Rescue 08 September 2021 Antares Pharma to Participate in the H.C. Wainright 23rd Annual Global Investment Conference 05 August 2021 Antares Pharma Reports Second Quarter 2021 Financial And Operating Results 28 July 2021 Antares Pharma to Report Second Quarter 2021 Financial and Operating Results 22 July 2021 Antares Pharma Announces FDA Acceptance of IND Application for ATRS 1902 For Adrenal Crisis Rescue 07 July 2021 Antares Pharma To Present At The Ladenburg Thalmann Annual Healthcare Conference 28 June 2021 Antares Pharma Announces Partner Idorsia Initiates The Phase 3 Study with Selatogrel For Acute Myocardial Infarction 22 June 2021 Antares Pharma Announces Submission of IND Application for ATRS 1902 For Adrenal Crisis Rescue 15 June 2021 Antares Pharma to Present at the Raymond James Human Health Innovations Conference 26 May 2021 Antares Pharma to Present at the Jefferies Virtual Healthcare Conference 06 May 2021 Antares Pharma Reports First Quarter 2021 Financial and Operating Results 06 May 2021 Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial 03 May 2021 Antares Pharma Announces Poster Presentation At The Pediatric Endocrine Society 2021 Virtual Annual Meeting 28 April 2021 Antares Pharma To Participate In The 7th Annual Truist Securities 2021 Life Sciences Summit 27 April 2021 Antares Pharma to Report First Quarter 2021 Financial and Operating Results 26 April 2021 Antares Pharma Appoints Dr. Peter Richardson As Executive Vice President, Research And Development And Chief Medical Officer 02 March 2021 Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results 24 February 2021 Antares Pharma to Present At Two Upcoming Investor Conferences 23 February 2021 Antares Pharma to Report Fourth Quarter And Full-Year 2020 Financial and Operating Results 17 February 2021 Antares Pharma to Participate in the SVB Leerink 10th Annual Virtual Global Healthcare Conference 11 January 2021 Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million For Investors Press SEC Filings Webcasts & Presentations Analyst Coverage Corporate Governance and Committee Charters Press Release Archive 2021 2020 2019 2018 2017 2016 Sign up for breaking news on ATRS * indicates required Email Address * First Name Last Name Company This site ©2021 Antares Pharma. All Rights Reserved About Antares Medicines For Partners For Investors For Patients Careers Contact Us Privacy Policy